Gilead

Gilead to Invest $5B in Galapagos Partnership
Strategy

Gilead to Invest $5B in Galapagos Partnership

The deal expands Gilead's investment in the European biotech as it seeks to add assets to its drug portfolio.
By Matthew Heller | July 15, 2019
Read More
Allergan Bets on Tobira’s Liver Disease Drug
Strategy

Allergan Bets on Tobira’s Liver Disease Drug

The Botox maker will pay up to $1.7 billion for Tobira, the developer of an experimental treatment for a nonalcoholic fatty liver condition.
By Matthew Heller | September 20, 2016
Read More
SEC Charges CPA, 4 Others With Insider Trading
Risk & Compliance

SEC Charges CPA, 4 Others With Insider Trading

The defendants allegedly made $234,000 by trading in Pharmasset shares based on nonpublic information about a takeover offer.
By Matthew Heller | September 28, 2015
Read More